Clinical Trial Update: Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) [Phase 2]

View source ↗

Summary

Long-term extension study assessing vamorolone in boys with Duchenne muscular dystrophy has completed Phase 2 trial and results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Vamorolone (vamorolone)

Snippet

Sponsor: ReveraGen BioPharma, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED | Results posted: 2021-05-20